29 research outputs found

    REDUCTION MAMMAPLASTY, AUGMENTATION MAMMAPLASTY, AND MASTOPEXY

    No full text

    BREAST RECONSTRUCTION

    No full text

    Infected implants

    No full text
    This chapter addresses infections associated with artificial devices of a specialized nature. The rate of infection is generally low, but collectively, there are millions of these devices implanted yearly, so the infections are not rare. Optimal treatment requires participation of surgical specialists experienced in the management of these difficult infections, especially for pseudophakic endophthalmitis, in which therapy includes intraocular injections.Intraocular lens-associated infections (pseudophakic endophthalmitis)Pseudophakic endophthalmitis is thought to occur as a consequence of contamination with flora of conjunctival sac or lid margin at the time of surgery. There also have been reports of infections arising from contamination of lenses and neutralizing and storage solutions.The differential diagnosis of endophthalmitis following cataract extraction includes sterile inflammation as well as bacterial and fungal infection. The most common presenting signs and symptoms include pain in the involved eye, decreased visual acuity, red eye, lid edema, hypopyon, and absent or poor red reflex. A single bacterial strain is usually isolated; the most common pathogen is a coagulase-negative staphylococcus (approximately 50% in one large series) followed by Staphylococcus aureus. Virtually any microorganism can be implicated. Delayed onset pseudophakic endophthalmitis has been reported after uncomplicated initial cataract surgery. This entity presents one or more months after surgery and is manifest by waxing and waning ocular inflammation. The leading cause of delayed-onset pseudophakic endophthalmitis is Propionibacterium acnes. Diagnostic evaluation requires aqueous and vitreous samples for Gram stain and culture. Vitrectomy may have therapeutic as well as diagnostic value

    Postoperative Antibiotic Prophylaxis for Implant-Based Breast Reconstruction with Acellular Dermal Matrix

    No full text
    Background: The use of acellular dermal matrix in implant-based breast reconstruction has been described for improving inferolateral prosthesis coverage and support and inframammary fold reconstruction. Recommended guidelines for infection prophylaxis are the same as for any clean procedure-antibiotic administration only before surgery. Previous studies have demonstrated increased postoperative rates of infection and seroma associated with the use of acellular dermal matrix. The authors evaluated the impact of postoperative antibiotic prophylaxis on infection rates in postmastectomy expander-based breast reconstruction with acellular dermal matrix. Methods: A retrospective study reviewed data of 96 patients who underwent either immediate or delayed expander-based breast reconstruction using Allo-Derm allogenic acellular dermal matrix. Infection rates were analyzed after patients received postoperative antibiotic prophylaxis for at least 48 hours compared with those who received only perioperative antibiotics. Results: Infection rates for breast reconstructions with a postoperative antibiotic course were 7.9 and 3.2 percent. Patients with only perioperative antibiotics had an infection rate of 31.6 percent. Infections were defined by the endpoint of implant removal. Patient demographics, comorbidities, and intraoperative variables were recorded. Uncontrolled variables were time course between mastectomy and reconstruction, nodal dissection, operative history, and whether reconstruction was unilateral or bilateral. Conclusions: This study demonstrates significant differences in the rate of infection between the groups of patients undergoing the first stage of two-stage implant-based breast reconstruction who received postoperative antibiotic prophylaxis and the group that received only perioperative antibiotics. This study suggests that the optimal duration of postoperative antibiotic prophylaxis is at least 48 hours. (Plast. Reconstr. Surg. 131: 453, 2013.) CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III

    Plastic Reconstructive and Aesthetic Surgery

    No full text
    Key Features:Its presentation is aligned with plastic surgery commonly encountered plastic surgery casesConcise but comprehensive presentation of a basic pool of knowledge in plastic surgeryMay be used as an adjunct for study preparationNumerous figures in the book are available in full color in the enclosed DVD-ROM
    corecore